Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	112	99	276	486	1,139	1,204
Market Cap Growth	-60.59%	-64.09%	-43.20%	-57.36%	-5.35%	111.61%
Enterprise Value	138	84	175	431	1,018	1,065
PE Ratio	-	-0.69	-1.67	-3.91	-5.80	-6.03
PS Ratio	0.79	0.68	1.76	2.32	10.54	29.44
PB Ratio	-1.03	-0.73	-16.57	-6.10	22.54	24.18
P/FCF Ratio	-1.48	-1.07	-1.84	-4.53	-7.10	-6.30
P/OCF Ratio	-1.48	-1.07	-1.84	-4.53	-7.11	-6.31
EV/Sales Ratio	0.98	0.57	1.12	2.05	9.42	26.03
EV/EBITDA Ratio	-1.65	-0.71	-1.26	-4.44	-6.07	-5.82
EV/EBIT Ratio	-1.65	-0.70	-1.25	-4.41	-6.03	-5.79
EV/FCF Ratio	-1.71	-0.90	-1.17	-4.01	-6.35	-5.57
Debt / Equity Ratio	-1.04	-1.30	-10.75	-2.27	2.59	2.51
Debt / EBITDA Ratio	-1.45	-1.49	-1.29	-1.86	-0.78	-0.68
Debt / FCF Ratio	-1.50	-1.91	-1.20	-1.68	-0.82	-0.65
Quick Ratio	2.76	3.16	4.96	3.50	4.41	5.86
Current Ratio	3.04	3.37	5.31	3.74	4.59	6.01
Asset Turnover	0.56	0.52	0.55	0.75	0.30	0.15
Interest Coverage	-5.10	-4.99	-5.60	-3.75	-6.22	-11.75
Return on Equity (ROE)	122.80%	162.10%	185.50%	151.10%	-182.50%	-254.70%
Return on Assets (ROA)	-57.80%	-50.50%	-58.00%	-44.30%	-54.30%	-71.40%
Return on Capital (ROIC)	-1769.82%	-317.42%	-87.55%	-97.39%	-94.59%	-108.48%
Earnings Yield	-131.94%	-144.44%	-59.90%	-25.54%	-17.23%	-16.58%
FCF Yield	-106.15%	-93.59%	-54.24%	-22.09%	-14.08%	-15.87%
Buyback Yield / Dilution	-1.74%	-39.51%	-8.84%	-4.41%	-16.28%	-9.11%
Total Shareholder Return	-1.74%	-39.51%	-8.84%	-4.41%	-16.28%	-9.11%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).